ClinicalTrials.gg
Sign In

Leukemia, Myelogenous, Chronic, BCR-ABL Positive clinical trials

The registry lists 894 studies for Leukemia, Myelogenous, Chronic, BCR-ABL Positive across more than 10 countries. 109 are recruiting or about to start. 516 of them are mainly about Leukemia, Myelogenous, Chronic, BCR-ABL Positive (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13. Counting its 3 narrower conditions too, such as Leukemia, Myeloid, Chronic-Phase: 1,316 studies, 129 open.

ClinicalTrials.gov finds 1,303 studies for Leukemia, Myelogenous, Chronic, BCR-ABL Positive. How that becomes 894 here

This page counts the studies the registry files under Leukemia, Myelogenous, Chronic, BCR-ABL Positive, and those it files under no condition that list Leukemia, Myelogenous, Chronic, BCR-ABL Positivethemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,303Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −418Filed under a narrower condition, counted on its own pageLeukemia, Myeloid, Chronic-Phase 314 · Blast Crisis 96 · Leukemia, Myeloid, Accelerated Phase 8
  3. −1List Leukemia, Myelogenous, Chronic, BCR-ABL Positive as a condition, but the registry did not file them under itMost often written as “Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative” (1) and “Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive” (1). The registry filed them under other conditions only, most often Leukemia, Biphenotypic, Acute (1) and Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1).
  4. −6Match it another way3 name it in the title and 3 by a synonym or other text the search reads.
  5. 878Counted here and found by its search
  6. +16
    Counted here, but its search does not find them
  7. 894The count on this page

Get an email when these change. Save the Leukemia, Myelogenous, Chronic, BCR-ABL Positive studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
478
Terminated
142
Recruiting
79
Status unknown
75
Active, not recruiting
44
Withdrawn
35

Phase

Phase 2
408
Phase 1
232
Phase 3
86
Phase 4
31
Early Phase 1
6

Where

United States
516
France
103
Italy
93
Germany
90
Canada
66
United Kingdom
57

Who runs them

Novartis Pharmaceuticals (86) · M.D. Anderson Cancer Center (75) · Fred Hutchinson Cancer Center (30) · National Cancer Institute (NCI) (27) · Bristol-Myers Squibb (23) · National Heart, Lung, and Blood Institute (NHLBI) (23) · Masonic Cancer Center, University of Minnesota (22) · Gruppo Italiano Malattie EMatologiche dell'Adulto (21)

What is being tested here

Drugs under test in Leukemia, Myelogenous, Chronic, BCR-ABL Positive studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Asciminib8520
Fludarabine5358
Cyclophosphamide5455
Dasatinib4444
Meribatinib316
Relcobatinib313
Embibatinib313
Nilotinib21666
Fludarabine phosphate2025
Ponatinib2217

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 26 open · Alkylating agents 7 open · Antimetabolites 6 open · Calcineurin inhibitors 2 open · JAK inhibitors 1 open

Coming up

8phase 3 studies under way
43studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 79 Leukemia, Myelogenous, Chronic, BCR-ABL Positive studies recruiting now, 48 (61%) set no upper age limit and 20 (25%) stop at 75 or younger. 20 (25%) take children under 18. 0 (0%) are for women only and 1 (1%) for men only; 7 (9%) take healthy volunteers.

Recruiting studies that take each age, of 79
AgeWomenMen
1017 (22%)17 (22%)
1875 (95%)76 (96%)
3073 (92%)74 (94%)
4072 (91%)73 (92%)
5072 (91%)73 (92%)
6570 (89%)71 (90%)
7563 (80%)64 (81%)
8556 (71%)56 (71%)

Across all 894 studies, recruiting or not: 35% stop at 75 or younger and 20% at 65; 29% take children; <1% are for women only and 1% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Leukemia, Myelogenous, Chronic, BCR-ABL Positive studies take

Of 126 phase 2 interventional studies under Leukemia, Myelogenous, Chronic, BCR-ABL Positive, half reached primary completion within 73 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 158 mo41–95 · 56 studies——
Phase 1/269 mo56–94 · 26 studies——
Phase 273 mo43–124 · 126 studies44 mo33–69 · 25 studies75 mo50–130 · 101 studies
Phase 338 mo30–79 · 24 studies——
Interventional, no phase41 mo22–123 · 25 studies——
Observational53 mo39–103 · 67 studies—58 mo46–142 · 45 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting3

Results posted1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 894. Browse all 894 → or search them.